Table 4.
Concentrations (pg/ml) of different cytokines in patients who spontaneously cleared HCV (CHS) and who developed chronic HCV infections (CHC).
| Cytokines/Adhesion molecular | CHS | CHC | P value |
|---|---|---|---|
| GM-CSF† | 115.26(57.65–147.825) | 140.66(71.08–191.70) | 0.183 |
| ICAM-1‡ | 68,720.44(45,056.51–116,732.54) | 82,258.86(43,367.80–114,235.32) | 0.889 |
| IFN-γ‡ | 33.92(24.64–46.51) | 48.51(37.79–63.39) | 0.001 |
| IFN-α‡ | 4.80(3.38–7.46) | 6.65(5.31–8.82) | 0.003 |
| IL-1α‡ | 2.91(1.79–5.29) | 4.12(2.80–5.96) | 0.041 |
| IL-1β‡ | 21.17(10.64–38.11) | 28.015(18.81–45.12) | 0.063 |
| IL-10 ‡ | 7.53(4.06–15.35) | 14.21(7.99–20.75) | 0.004 |
| IL-12p70† | 62.70(35.02–85.37) | 78.31(49.39–97.72) | 0.066 |
| IL-13‡ | 10.17(7.17–12.61) | 12.44(9.13–17.00) | 0.016 |
| IL-17A‡ | 40.75(30.06–68.36) | 57.16(39.68–76.21) | 0.083 |
| IL-4‡ | 51.73(35.00–78.26) | 66.32(51.49–92.71) | 0.009 |
| IL-8‡ | 8.11(5.28–12.39) | 8.72(6.49–13.56) | 0.207 |
| IP-10‡ | 37.13(26.44–52.86) | 39.51(31.04–50.86) | 0.457 |
| MCP-1‡ | 71.56(55.67–88.87) | 60.8(48.29–77.23) | 0.077 |
| IL-6† | 106.86(38.24–167.14) | 146.66(71.65–220.54) | 0.043 |
| MIP-1α‡ | 9.89(7.95–13.50) | 11.27(9.41–14.07) | 0.067 |
| MIP-1β‡ | 33.88(24.39–51.27) | 39.29(27.38–50.50) | 0.264 |
| sE-Selectin‡ | 16,315.12(13,429.26–24,404.89) | 14,289.16(11,076.44–19,454.89) | 0.073 |
| sP-Selectin‡ | 317,447.58(114,555.89–1,309,209.36) | 544,538.59(231,481.54–1,221,184.48) | 0.294 |
| TNF-α‡ | 63.045(46.05–86.24) | 96.96(62.46–107.47) | 0.000 |
†Normally distributed continuous variables. Mean concentration (IQR).
‡Abnormal distribution continuous variables. Median concentration (IQR). N = 36 for CHS group and N = 50 for CHC group.